NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane

Antioxid Redox Signal. 2000 Summer;2(2):251-62. doi: 10.1089/ars.2000.2.2-251.

Abstract

High affinity for NADH, and low affinity for NADPH, for reduction of endogenous coenzyme Q10 (CoQ10) by pig liver plasma membrane is reported in the present work. CoQ reduction in plasma membrane is carried out, in addition to other mechanisms, by plasma membrane coenzyme Q reductase (PMQR). We show that PMQR-catalyzed reduction of CoQ0 by both NADH and NADPH is accompanied by generation of CoQ0 semiquinone radicals in a superoxide-dependent reaction. In the presence of a water-soluble vitamin E homologue, Trolox, this reduction leads to quenching of the Trolox phenoxyl radicals. The involvement of PMQR versus DT-diaphorase under the conditions of vitamin E and selenium sufficiency and deficiency was evaluated for CoQ reduction by plasma membranes. The data presented here suggest that both nucleotides (NADH and NADPH) can be accountable for CoQ reduction by PMQR on the basis of their physiological concentrations within the cell. The enzyme is primarily responsible for CoQ reduction in plasma membrane under normal (nonoxidative stress-associated) conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Cell Membrane / enzymology*
  • Chromans / pharmacology
  • Coenzymes
  • Cytochrome c Group / metabolism
  • Dose-Response Relationship, Drug
  • Electron Spin Resonance Spectroscopy
  • Electron Transport
  • Kinetics
  • Liver / enzymology*
  • Male
  • NAD / metabolism*
  • NADP / metabolism*
  • Oxidative Stress
  • Rats
  • Rats, Long-Evans
  • Selenium / metabolism
  • Superoxides / metabolism
  • Swine
  • Ubiquinone / analogs & derivatives
  • Ubiquinone / metabolism*
  • Vitamin E / metabolism

Substances

  • Antioxidants
  • Chromans
  • Coenzymes
  • Cytochrome c Group
  • NAD
  • Superoxides
  • Ubiquinone
  • Vitamin E
  • NADP
  • coenzyme Q10
  • Selenium
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid